Tag: AI chatbots

Browse our exclusive articles!

ChatGPT’s Growing Usability in Software Development: A TechTarget Perspective

Discover how AI chatbots like ChatGPT are helping developers learn new programming languages and simplify tasks in software development, with some limitations.

OpenAI shuts down conservative chatbot GPT-2 on Tusk app

OpenAI's decision to shut down a conservative chatbot has sparked debate about free speech and tech influence. Critics say such actions stifle diversity of thought while others argue content moderation is necessary for combating harmful content. The incident raises important questions about the future development of AI chatbots.

Hyro Secures $20M Funding to Expand Plug-and-Play AI Assistants

Hyro raises $20m in funding to expand its AI-driven call centers, apps and websites. The company provides an AI enterprise platform for businesses to easily incorporate conversational AI. Hyro stands out by swiftly creating a fully functional AI assistant for prospects using their data. Their AI-chatbots for healthcare automate tasks and handle up to 70% of calls and messages.

Xiao-I, a Chinese AI chatbot company, aims for the global market after a successful Nasdaq IPO frenzy on ChatGPT.

Xiao-I's Nasdaq success seals its position as a dominant global player in the AI chatbot market, with a valuation exceeding $400 million.

Improving the Reliability of AI Chatbots: Can OpenAI and Google Solve the Issue?

Researchers are working on preventing hallucinations in AI chatbots to avoid providing false information. Various companies use different tactics for this purpose, including human trainers and having multiple chatbots answer questions before choosing the correct one. Though SelfCheckGPT seems promising, the perfect solution is yet to be found.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img